Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Celera to Webcast its Presentation at Two Healthcare Conferences in September
Presenting September 9 at the Thomas Weisel Partners Healthcare Conference and September 22 at the UBS Global Life Sciences Conference

ALAMEDA, CA - September 02, 2009

Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentations at two upcoming financial conferences in September. Celera will webcast its presentation at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 9, 2009. The live webcast is scheduled to begin at 3:50 pm ET. Ugo DeBlasi, Chief Financial Officer at Celera, and David Speechly, Ph.D., Vice President of Corporate Affairs at Celera will provide a brief overview of Celera’s business, followed by a question and answer session with investors and a Thomas Weisel Partners financial analyst.

Celera will also webcast its presentation at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009. The live webcast is scheduled to begin at 8:00 am ET when Kathy Ordońez, Chief Executive Officer of Celera, will provide an overview of the Company’s business.

Interested parties may access the live webcasts and replay by visiting the Media and Investors section of the Celera website at www.celera.com. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Media and Investors section of the website.

About Celera
Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the Company with the Securities and Exchange Commission, is available at http://www.celera.com.

Copyright© 2009. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.

Contact:

Celera
David Speechly, Ph.D.
+1 (510) 749-1853
David.Speechly@celera.com


Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.